Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Autistic Disorder × Everolimus × Clear all

Phase

Status

Completed 3 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Neoplasm Metastasis 6 Neoplasms 4 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Neuroendocrine 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Sarcoma 1 Renal Cell Cancer Metastatic 1 Relapsed Pediatric Solid Tumor 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Metatropic dwarfism 1 Liver Neoplasms 1 Liver Failure 1 Liver Diseases 1 Liver Cirrhosis 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia 1

Interventions

Medical Marijuana 1 Everolimus 1 Activator Appliances 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730209 2015-05-05

RAPIT

Erasmus Medical Center

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡